KST-6051 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Trump administration loses Alaska Senate ballot case as judge rejects election delay

Whitehaven Coal’s A$1bn Winchester South project clears major court hurdle but approvals remain outstanding

Sun Pharmaceutical (SUNPHARMA) gains US approval for ILUMYA as Q2 profit falls 36%

Macmahon completes A$75m Aspect Engineering acquisition with 6.2% earnings accretion forecast

Read More

Pharma Industry News

Can KST-6051 unlock broader KRAS cancer treatment beyond G12C inhibitors

KST-6051 enters Phase 1 with AbbVie Inc. backing. Discover how pan-KRAS inhibitors could expand treatment across KRAS-driven cancers.

bySoujanya Ravi

May 1, 2026

web analytics